Myochrysine User Reviews & Ratings
Myochrysine has an average rating of 5.5 out of 10 from a total of 2 reviews on Drugs.com. 50% of reviewers reported a positive experience, while 50% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Rheumatoid Arthritis | 2 reviews for Rheumatoid Arthritis | 373 medications | |
Add your review |
- Mary
- Taken for 2 to 5 years
- March 9, 2023
For Rheumatoid Arthritis "At 21 years of age, I was prescribed Myochrysine injections for chronic juvenile rheumatoid arthritis. I had suffered horribly from JRA as an infant, through childhood and into adulthood. I was on gold for 4 years until I was 25, one injection each month. It seemed to put my RA in remission. However, after 4 years with no complications, immediately after a routine injection, while driving back to work from my doctor's office, I went into Anaphylactic shock. I almost died. I was permanently taken off of gold. I have mixed feelings about Myochrysine."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Myochrysine (gold sodium thiomalate)
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
For Rheumatoid Arthritis "I have been on Myochrysine 50mg for 33 years , one injection a month, you would never know I have severe rheumatoid arthritis, my doctor took blood once a month did a CBC and UA, never had a problem, of course its been discontinued now altogether. I have bought this medicine from Vanuatu, India, Barbados, Canada and most recently the United Kingdom, but now it’s no more, I believe it has been discontinued because it works! Not enough profit for drug company’s."